{"doi":"10.1111/acel.70358","title":"Senolytic‐Resistant Senescent Cells Have a Distinct <scp>SASP</scp> Profile and Functional Impact: The Path to Developing Senosensitizers","abstract":"ABSTRACT The senescent cell (SC) fate is linked to aging, multiple disorders and diseases, and physical dysfunction. Senolytics, agents that selectively eliminate 30%–70% of SCs, act by transiently disabling the senescent cell antiapoptotic pathways (SCAPs), which defend those SCs that are proapoptotic and pro‐inflammatory from their own senescence‐associated secretory phenotype (SASP). Consistent with this, a JAK/STAT inhibitor, Ruxolitinib, which attenuates the pro‐inflammatory SASP of senescent human preadipocytes, caused them to become “senolytic‐resistant”. Administering senolytics to obese mice selectively decreased the abundance of the subset of SCs that is pro‐inflammatory. In cell cultures, the 30%–70% of human senescent preadipocytes or human umbilical vein endothelial cells (HUVECs) that are senolytic‐resistant (to Dasatinib or Quercetin, respectively) had increased p16 INK4a , p21 CIP1 , senescence‐associated β‐galactosidase (SAβgal), γH2AX, and proliferative arrest similarly to the total SC population (comprising senolytic‐sensitive plus‐resistant SCs). However, the SASP of senolytic‐resistant SCs entailed less pro‐inflammatory/apoptotic factor production, induced less inflammation in non‐senescent cells, and was equivalent or richer in growth/fibrotic factors. Senolytic‐resistant SCs released less mitochondrial DNA (mtDNA) and more highly expressed the anti‐inflammatory immune evasion signal, glycoprotein non‐melanoma‐B (GPNMB). Transplanting senolytic‐resistant SCs intraperitoneally into younger mice caused less physical dysfunction than transplanting the total SC population. Because Ruxolitinib attenuates SC release of proapoptotic SASP factors, while pathogen‐associated molecular pattern factors (PAMPs) can amplify the release of these factors rapidly (acting as “senosensitizers”), senolytic‐resistant and senolytic‐sensitive SCs appear to be interconvertible.","journal":"Aging Cell","year":2025,"id":515402,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":6,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9534,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1019916,"name":"Masayoshi Suda","orcid":"0000-0002-3415-6236","position":1,"is_corresponding":false},{"id":1371745,"name":"Vagisha Kulshreshtha","orcid":"0000-0002-2293-0749","position":2,"is_corresponding":false},{"id":1276105,"name":"Bryan T Piatkowski","orcid":null,"position":3,"is_corresponding":false},{"id":268238,"name":"Allyson K. Palmer","orcid":"0000-0001-7505-3455","position":4,"is_corresponding":false},{"id":643304,"name":"Nino Giorgadze","orcid":null,"position":5,"is_corresponding":false},{"id":300038,"name":"Christina L. Inman","orcid":null,"position":6,"is_corresponding":false},{"id":616010,"name":"Nathan Gasek","orcid":"0000-0002-3501-6681","position":7,"is_corresponding":false},{"id":123129,"name":"Ming Xu","orcid":null,"position":8,"is_corresponding":false},{"id":617583,"name":"Kurt O. Johnson","orcid":"0000-0003-0682-4687","position":9,"is_corresponding":false},{"id":571781,"name":"Tamar Pirtskhalava","orcid":null,"position":10,"is_corresponding":false},{"id":787940,"name":"Selim Chaib","orcid":"0000-0003-0497-2002","position":11,"is_corresponding":false},{"id":1380319,"name":"Larissa P. G. Langhi Prata","orcid":null,"position":12,"is_corresponding":false},{"id":255149,"name":"Yi Zhu","orcid":"0000-0002-3876-3156","position":13,"is_corresponding":false},{"id":539669,"name":"Renuka Kandhaya‐Pillai","orcid":"0000-0001-7571-7725","position":14,"is_corresponding":false},{"id":1380320,"name":"S. Tullius","orcid":null,"position":15,"is_corresponding":false},{"id":1030736,"name":"Saranya P. Wyles","orcid":"0000-0002-0406-7427","position":16,"is_corresponding":false},{"id":1380321,"name":"Rambabu Majji","orcid":null,"position":17,"is_corresponding":false},{"id":288606,"name":"Hari Krishna Yalamanchili","orcid":"0000-0001-9892-3054","position":18,"is_corresponding":false},{"id":71621,"name":"David B. Allison","orcid":"0000-0003-3566-9399","position":19,"is_corresponding":false},{"id":106953,"name":"Tamar Tchkonia","orcid":"0000-0003-4623-7145","position":20,"is_corresponding":false},{"id":106952,"name":"James L. Kirkland","orcid":"0000-0003-1676-4905","position":21,"is_corresponding":false},{"id":1379698,"name":"Utkarsh Tripathi","orcid":"0000-0002-4994-629X","position":0,"is_corresponding":true}],"reference_count":63,"raw_metadata":null,"created_at":"2026-07-19T02:48:39.436300Z","pmid":"41462575","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}